Effect of an amyloidogenic sequence attached to yellow fluorescent protein

Proteins: Structure, Function and Genetics

Volumn 72, Issue 3, 2008, Pages 811-821

  Hamada, Daizo ^a,b,f   Tsumoto, Kouhei ^c   Sawara, Makoto ^d   Tanaka, Naoki ^e   Nakahira, Kumiko ^b   Shiraki, Kentaro ^d,g   Yanagihara, Itaru ^b  

^a OSAKA UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^e KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

AFM; Amyloid fibril; Infrared spectroscopy; Protein misfolding; TEM

Indexed keywords

AMYLOID PROTEIN; HYBRID PROTEIN; MEDIN; YELLOW FLUORESCENT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; EPIFLUORESCENCE MICROSCOPE; INFRARED RADIATION; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SEQUENCE; AMYLOID; ANTIGENS, SURFACE; BACTERIAL PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MILK PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 47349117210     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21971     Document Type: Article

References (45)

1. Jeyashekar NS, Sadana A, Vo-Dinh T. Protein amyloidose misfolding: mechanisms, detection, and pathological implications. Methods Mol Biol 2005;300:417-435.
2. Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 2004;1739:5-25.
3. Nayeem MS, Khan RH. Misfolded proteins and human diseases. Protein Pept Lett 2004;11:593-600.
4. Dobson CM. The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 2001;356:133-145.
5. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999;96:3590-3594.
6. Chiti F, Bucciantini M, Capanni C, Taddei N, Dobson CM, Stefani M. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain. Protein Sci 2001;10:2541-2547.
7. Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 1998;95:4224-4228.
8. Hamada D, Dobson CM. A kinetic study of β-lactoglobulin amyloid fibril formation promoted by urea. Protein Sci 2002;11:2417-2426.
9. Pertinhez TA, Bouchard M, Tomlinson EJ, Wain R, Ferguson SJ, Dobson CM, Smith LJ. Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS. FEBS Lett 2001;495:184-186.
10. Fändrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001;410:165-166.
11. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003;424:805-808.
12. DuBay KF, Pawar AP, Chiti F, Zurdo J, Dobson CM, Vendruscolo M. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol 2004;341:1317-1326.
13. Uversky VN, Fink AL. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 2004;1698:131-153.
14. Makin OS, Serpell LC. Examining the structure of the mature amyloid fibril. Biochem Soc Trans 2002;30:521-525.
15. Wetzel R. Ideas of order for amyloid fibril structure. Structure 2002;10:1031-1036.
16. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Reikel C, Grothe R, Eisenberg D. Structure of the cross-β spine of amyloid-like fibrils. Nature 2005;435:747-749.
17. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJW, McFarlane HT, Madsen AØ, Reikel C, Eisenberg D. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 2007;447:453-457.
18. Pallares I, Vendrell J, Aviles FX, Ventura S. Amyloid fibril formation by a partially structured intermediate state of α-chymotrypsin. J Mol Biol 2004;342:321-331.
19. Vernaglia BA, Huang J, Clark ED. Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme. Biomacromolecules 2004;5:1362-1370.
20. Kim YS, Randolph TW, Manning MC, Stevens FJ, Carpenter JF. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation. J Biol Chem 2003;278:10842-10850.
21. Quintas A, Vaz DC, Carsoso I, Saraiva MJ, Brito RM. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 2001;276:27207-27213.
22. Khurana R, Gillespie JR, Talapatra A, Minert LJ, Ionescu-Zanetti C, Millett I, Fink AL. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 2001;40:3525-3535.
23. Nettleton EJ, Sunde M, Lai Z, Kelly JW, Dobson CM, Robinson CV. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. J Mol Biol 1998;281:553-564.
24. Dima RI, Thirumalai D. Exploring protein aggregation and self-propagation using lattice models: phase diagram and kinetics. Protein Sci 2002;11:1036-1049.
25. Monti M, Leij Garolla di Bard B, Calloni G, Chiti F, Amoresano A, Ramponi G, Pucci P. The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. J Mol Biol 2004;336:253-262.
26. Ventura S. Sequence determinants of protein aggregation: tools to increase protein solubility. Microb Cell Fact 2005;4:11.
27. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 1999;17:691-695.
28. Wurth C, Guimard NK, Hecht MH. Mutations that reduce aggregation of the Alzheimer's Aβ42 peptide: an unbiased search for the sequence determinants of Aβ amyloidogenesis. J Mol Biol 2002;319:1279-1290.
29. Baxa U, Speransky V, Steven AC, Wickner RB. Mechanism of inactivation on prion coversion of the Saccharomyces cerevisiae Ure2 protein. Proc Natl Acad Sci USA 2002;99:5253-5260.
30. Glover JR, Kowal AS, Schirmer EC, Patino MM, Liu JJ, Lindquist S. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 1997;89:811-819.
31. Serio TR, Cashikar AG, Moslehi JJ, Kowal AS, Lindquist SL. Yeast prion [psi+] and its determinant. Sup35p Methods Enzymol 1999;309:649-673.
32. Li L, Lindquist SL. Creating a protein-based element of inheritance. Science 2000;287:661-664.
33. Lin H, Huai Q, Huang M, Furie B, Furie BC. Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII. J Mol Biol 2007;371:717-724.
34. Wickner RB, Masison DC. Evidence for two prions in yeast: [URE3] and [PSI]. Curr Top Microbiol Immunol 1996;207:147-160.
35. Wickner RB, Edskes HK, Roberts BT, Pierce M, Baxa U. Prions of yeast as epigenetic phonomena: high protein "copy number" inducing protein "silencing." Adv Genet 2002;46:485-525.
36. Serio TR, Lindquist SL. Protein-only inheritance in yeast: something to get [PSI+]-ched about. Trends Cell Biol 2001;10:98-105.
37. Serio TR, Lindquist SL. The yeast prion [PSI+]: molecule insights and functional consequences. Adv Protein Chem 2001;57:335-366.
38. Bai M, Zhou J-M, Perrett S. The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms. J Biol Chem 2004;279:50025-50030.
39. Bousset L, Thomson NH, Radford SE, Melki R. The yeast prion Ure2p retains its native α-helical conformation upon assembly into protein fibrils in vitro. EMBO J 2002;21:2903-2911.
40. Häggqvist B, Näslund J, Sletten K, Westermark GT, Mucchiano G, Tjernberg LO, Nordstedt C, Engstr̂m U, Westermark P. Medin: an integral fragment of aotic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci USA 1999;96:8669-8674.
41. Mucchiano G, Cornwell GG, III, Westermark P. Senile aortic amyloid. Evidence for two distinct forms of localized deposits. Am J Pathol 1992;140:871-877.
42. Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Biol Chem 2003;278:16462-16465.
43. Goormaghtigh E, Cabiaux V, Ruysschaert JM. Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem 1990;193:409-420.
44. Ogawa H, Inouye S, Tsuji FI, Yasuda K, Umesono K. Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc Natl Acad Sci USA 1995;92:11899-11903.
45. Hamada D, Yanagihara I, Tsumoto K. Engineering amyloidogenicity towards the development of nanofibrillar materials. Trends Biotechnol 2004;22:93-97.